Form 4: BioCardia Director Krasno Acquires Shares and Warrants in Private Placement

Director Richard M. Krasno acquired 13,123 shares of BioCardia, Inc. common stock and warrants in a private placement on April 23, 2025.

Summary

• Richard M. Krasno, a director of BioCardia, Inc., acquired 13,123 shares of common stock and warrants to purchase an equal number of shares through a private placement.
• The transaction occurred on April 23, 2025, with the shares and warrants priced at $1.905 each.
• Following the transaction, Krasno directly owns 16,268 shares of BioCardia common stock.
• The warrants are exercisable immediately and expire on April 23, 2030.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares is generally a good sign, but the late filing and small amount temper the enthusiasm.

Positives

• A director's investment in the company may signal confidence in BioCardia's future prospects.

Future Outlook

The document does not contain specific forward-looking statements, but the warrant exercise could provide future capital to the company if exercised.

Industry Context

Insider transactions are closely watched as indicators of management's view of the company's prospects. A director purchasing shares can be seen as a positive sign.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

BioCardia, BCDA, Richard Krasno, Form 4, insider trading, private placement, warrants, common stock, director